Case Type: Mergers & Acquisitions

Fifth Era Acquisition Corp. I (NASDAQ: FERA) related to its merger with SMT Holdings Limited.

Assertio Holdings, Inc. (NASDAQ: ASRT) related to its sale to Zydus Worldwide DMCC. Under the terms of the proposed transaction, Assertio shareholders are expected to receive $23.50 in cash per share.

Whitestone REIT (NYSE: WSR) related to its sale to Ares Management Corporation. Under the terms of the proposed transaction, Whitestone shareholders are expected to receive $19.00 in cash per share or unit.

Lakeside Bancshares, Inc. (OTCMKTS: LKSB) related to its sale to Catalyst Bancorp, Inc. Under the terms of the proposed transaction, Lakeside shareholders are expected to receive $19.58 in cash per share.

Odyssey Marine Exploration, Inc. (NASDAQ: OMEX) related to its merger with American Ocean Minerals Corporation.

McCormick & Company, Incorporated (NYSE: MKC) related to its merger with Unilever’s Foods business. Upon closing of the proposed transaction, McCormick shareholders will own approximately 35.0% of the combined company

Soleno Therapeutics, Inc. (NASDAQ: SLNO) related to its sale to Neurocrine Biosciences, Inc. Under the terms of the proposed transaction, Soleno shareholders are expected to receive $53.00 per share in cash.

Forian Inc. (NASDAQ: FORA) related to its sale to a consortium led by Max Wygod, Chairman and Chief Executive Officer, together with certain other senior executives and existing shareholders of the company. Under the terms of the proposed transaction, Forian shareholders are expected to receive $2.17 per share in cash.

Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) related to its merger with Korsana Biosciences, Inc. Upon the closing of the proposed transaction, Cyclerion shareholders are expected to own approximately 1.5% of the combined company.

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) related to its sale to Biogen, Inc. Under the terms of the proposed transaction, Apellis shareholders are expected to receive $41.00 per share in cash and a non-transferable contingent value right for the right to receive two payments of $2.00 per share each, contingent on certain annual global net sales thresholds being … Read more